egtazic acid has been researched along with epigallocatechin gallate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biffo, S; Burlando, B; Magnelli, V; Martinotti, S; Murer, B; Mutti, L; Ranzato, E | 1 |
Lee, MJ; Moon, SY; Park, SK; Yang, WS | 1 |
2 other study(ies) available for egtazic acid and epigallocatechin gallate
Article | Year |
---|---|
Epigallocatechin-3-gallate induces mesothelioma cell death via H2 O2 -dependent T-type Ca2+ channel opening.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Calcium; Calcium Channels, T-Type; Catalase; Catechin; Cell Death; Cell Line, Tumor; Chelating Agents; Dose-Response Relationship, Drug; Egtazic Acid; Humans; Hydrogen Peroxide; Mesothelioma; Mibefradil; Pleura; Pleural Neoplasms; Reactive Oxygen Species | 2012 |
Epigallocatechin-3-Gallate Attenuates the Effects of TNF-α in Vascular Endothelial Cells by Causing Ectodomain Shedding of TNF Receptor 1.
Topics: ADAM10 Protein; Blotting, Western; Calcium; Catechin; Cell Line; Cell Membrane; Egtazic Acid; Endothelial Cells; Endothelin-1; Gene Expression; Humans; Microscopy, Fluorescence; Receptors, Tumor Necrosis Factor, Type I; RNA Interference; RNA, Small Interfering; Tumor Necrosis Factor-alpha | 2016 |